PAPER Rinne JO, Koivunen J, Scheinin N, Aalto S, Vahlberg T, Någren K, Parkkola R, Viitanen M
SEARCH RESULTS
331159 RESULTS
PAPER Rentz DM, Becker JA, Frey MT, Carmasin J, Maye J, Olson L, Johnson KA, Sperling RA
A challenging test of name retrieval may be sensitive to early amyloid deposition in normals.
Human Amyloid Imaging 2010 Meeting Abstracts. 2010 April 9;PAPER Ramlackhansingh AF, Knight WD, Okello A, Ryan N, Turkheimer F, De Llano SR, Edison P, Douglas J, Fox NC, Brooks DJ
Amyloid imaging in presenilin 1 mutation carriers with 11C-PiB PET.
Human Amyloid Imaging 2010 Meeting Abstracts. 2010 April 9;PAPER Rabinovici GD, Alkalay A, Marchant NL, DeCarli C, Mungas DM, Chui HC, Reed BR, Jagust WJ
Contribution of amyloid and cerebrovascular disease to cognitive impairment in individuals with high vascular risk.
Human Amyloid Imaging 2010 Meeting Abstracts. 2010 April 9;PAPER Park DC, Rodrigue KM, Kennedy KM, Rieck JR, Hebrank AC, Devous MD
Amyloid burden in normal aging: The Dallas Lifespan Brain Study.
Human Amyloid Imaging 2010 Meeting Abstracts. 2010 April 9;PAPER Maye JE, Carmasin JS, Becker JA, Rentz DM, Sperling RA, Johnson KA
Maternal history of dementia is associated with amyloid deposition in clinically normal older individuals.
Human Amyloid Imaging 2010 Meeting Abstracts. 2010 April 9;PAPER Larvie M, Van Leemput K, Becker JA, Maye JE, Carmasin JS, Sperling RA, Fischl B, Johnson KA
Hippocampal substructural volume in relation to amyloid deposition.
Human Amyloid Imaging 2010 Meeting Abstracts. 2010 April 9;PAPER Langbaum JB, Chen K, Liu X, Fleisher AS, Reeder S, Bandy D, Alexander GE, Caselli RJ, Reiman EM
Association between pulse pressure and fibrillar amyloidbeta burden in cognitively normal, late middle-aged people at three levels of genetic risk for Alzheimer’s disease.
Human Amyloid Imaging 2010 Meeting Abstracts. 2010 April 9;PAPER Klunk WE, Snitz BE, Cohen AD, Price JC, Mathis CA, DeKosky ST, Lopez OL, Saxton JA
Comparison of longitudinal changes in amyloid deposition and cerebral metabolism in early-onset familial AD.
Human Amyloid Imaging 2010 Meeting Abstracts. 2010 April 9;PAPER Ikonomovic MD, Abrahamson EE, Mathis CA, Price JC, Srinivasan S, Debnath ML, Hamilton RL, DeKosky ST, Klunk WE
Histological comparison of neocortical β-amyloid plaque labeling using fluorescent derivatives of flutemetamol (3’-F-PiB) and PiB.
Human Amyloid Imaging 2010 Meeting Abstracts. 2010 April 9;PAPER Ichise M, Becker G, Barthel H, Patt M, Luthardt J, Gertz H-J, Schultze-Mosgau M, Rohde B, Reininger C, Sabri O
Kinetic modeling of florbetaben PET data to quantify β-amyloid binding in the human brain.
Human Amyloid Imaging 2010 Meeting Abstracts. 2010 April 9;PAPER Hatashita S, Yamasaki H
Progression of MCI associated with amyloid deposition using PIB PET imaging.
Human Amyloid Imaging 2010 Meeting Abstracts. 2010 April 9;PAPER Gomperts SN, Brück A, Locascio JJ, Rentz DM, Becker JA, Memole L, Carmasin J, Sperling RA, Growdon J, Johnson KA
Regional burden of Aβ-amyloid relates to cognitive function in Parkinson’s disease.
Human Amyloid Imaging 2010 Meeting Abstracts. 2010 April 9;PAPER Elmaleh DR, Shoup TM, Johnson K, Selkoe D, Fischman AJ
Evaluation of inositol and benzothiazole derivatives for amyloid-β peptide inhibition and amyloid imaging.
Human Amyloid Imaging 2010 Meeting Abstracts. 2010 April 9;PAPER Edison P, Hinz R, Ramlackhansingh A, Thomas J, Turkheimer FE, Brooks DJ
Can we use pons as a reference region for the analysis of [11C]PIB PET?
Human Amyloid Imaging 2010 Meeting Abstracts. 2010 April 9;Current Filters
No filters selected